<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01248078</url>
  </required_header>
  <id_info>
    <org_study_id>226/2003</org_study_id>
    <nct_id>NCT01248078</nct_id>
  </id_info>
  <brief_title>Antibiotic Prophylaxis Before Surgery Versus After Cord Clamping in Elective Cesarean Delivery - a Double-blind, Prospective, Randomized Placebo-controlled Trial</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective, randomized, placebo controlled trial the investigators were able to
      demonstrate the usefulness of prophylactic cefazolin in elective caesarean section versus
      placebo, irrespective of the timing of administration, ie before skin incision or after
      umbilical cord clamping
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background. Perioperative antibiotic prophylaxis during elective cesarean section at term to
      reduce postoperative maternal infectious morbidity is generally used but may not be efficient
      based on the available data. Also, the optimal timing of prophylactic antibiotic
      administration is unclear.

      Methods. The investigators compared the effectiveness of cefazolin, administered before skin
      incision versus after umbilical cord clamping versus placebo in a three-arm randomized trial.
      The primary endpoint of the study was postoperative infectious morbidity, defined as wound
      infection, endometritis, or urinary tract infection. Results: The primary outcome was
      observed in 18/370 women in group 1 (4.9%) and in 14/371 women in group 2 (3.8%), whereas it
      was noted in 45/371 women in group 3 (12.1%; p&lt;0.001 for group 1 vs. group 3; p&lt;0.001 for
      group 2 vs. group 3; p&lt;0.001 for group 1 vs. group 2 vs. group 3). The number needed to treat
      to avoid one primary outcome was 13. Comparing groups 1 and 2, there was no statistically
      significant difference regarding the primary outcome (p=0.6).

      Conclusions. In this prospective, randomized, placebo controlled trial the investigators were
      able to demonstrate the usefulness of prophylactic cefazolin in elective caesarean section
      versus placebo, irrespective of the timing of administration, ie before skin incision or
      after umbilical cord clamping.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2004</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative infectious morbidity</measure>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">1112</enrollment>
  <condition>Elective Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Cefazolin A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>administered before skin incision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cefazolin B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>after umbilical cord clamping</description>
  </arm_group>
  <arm_group>
    <arm_group_label>saline solution</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>administered before skin incision</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Keflex</intervention_name>
    <description>2g of i.v. cefazolin singleshot administered before skin incision</description>
    <arm_group_label>Cefazolin A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Keflex</intervention_name>
    <description>2g of i.v. cefazolin singleshot administered after umbilical cord clamping</description>
    <arm_group_label>Cefazolin B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline solution</intervention_name>
    <description>100cc administered before skin incision</description>
    <arm_group_label>saline solution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Elective cesarean section at term Patientin &gt;18 years Informed consent NO known allergy
        to cefazolin NO exposure to any antibiotic agent within 1 week prior to delivery

        Exclusion Criteria:

        - cesarean section before week 37 cephalosporin allergy age less than 18 years exposure to
        any antibiotic agent within 1 week prior to delivery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2010</study_first_submitted>
  <study_first_submitted_qc>November 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2010</study_first_posted>
  <last_update_submitted>November 24, 2010</last_update_submitted>
  <last_update_submitted_qc>November 24, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2010</last_update_posted>
  <responsible_party>
    <name_title>Armin Witt, MD</name_title>
    <organization>Medical University of Vienna</organization>
  </responsible_party>
  <keyword>elective cesarean section</keyword>
  <keyword>antibiotic prophylaxis</keyword>
  <keyword>cefazoline</keyword>
  <keyword>wound infection</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Cefazolin</mesh_term>
    <mesh_term>Cephalexin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

